SERPANRAY Drug Patent Profile
When do Serpanray patents expire, and what generic alternatives are available?
Serpanray is a drug marketed by Panray and is included in one NDA.
The generic ingredient in SERPANRAY is reserpine. There is one drug master file entry for this compound. Additional details are available on the reserpine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SERPANRAY?
- What are the global sales for SERPANRAY?
- What is Average Wholesale Price for SERPANRAY?
Summary for SERPANRAY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Patent Applications: | 404 |
| DailyMed Link: | SERPANRAY at DailyMed |
US Patents and Regulatory Information for SERPANRAY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
